Showing results (1951-1960 of 2,095) with videos related to

Sort By:
Pageof 210
Plos One|January 10, 2013
HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assaysShih-Wen Lin, Arpita Ghosh, Carolina Porras, et al.
The Journal of Pathology|February 6, 2007
Identification of a unique epigenetic sub-microenvironment in prostate cancerJ Rodriguez-Canales, J C Hanson, M A Tangrea, et al.
The Journal of Urology|April 25, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer ScreeningJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
The Lancet. HIV|April 29, 2021
Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trialAdriana Weinberg, Petronella Muresan, Lauren Laimon, et al.
Scientific Reports|July 2, 2024
Socioeconomic disparities and the genomic landscape of gastric cancerDaniel Zanabria, Marco Galvez-Nino, Jhajaira M Araujo, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of adaptive and innate immune responses induced by licensed vaccines for Human PapillomavirusDouglas M Herrin, Emily E Coates, Pamela J Costner, et al.
BMC Infectious Diseases|March 5, 2014
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirusHilary A Robbins, Yan Li, Carolina Porras, et al.
The Lancet. Global Health|February 16, 2024
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trialsKathy Baisley, Troy J Kemp, Nelly R Mugo, et al.
Oncogene|December 22, 2015
A new ER-specific photosensitizer unravels (1)O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDTA Pinto, Y Mace, F Drouet, et al.
Annals of Surgical Oncology|October 28, 2022
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)M Margaret Kemeny, Fengmin Zhao, Arlene A Forastiere, et al.
Pageof 210